Bioadaptives (BDPT) Operating Expenses (2013 - 2026)

Bioadaptives has disclosed Operating Expenses across 13 years of filings, most recently posting $202331.0 for Q1 2026.

• Operating Expenses for Q1 2026 came in at $202331.0, down 18.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 25.69% YoY), and the FY2025 annual result was $1.1 million, up 74.0% from the prior year.
• Operating Expenses came in at $202331.0 for Q1 2026 at Bioadaptives, down from $255700.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $337339.0 in Q4 2024 to a low of $20955.0 in Q1 2023.
• The 5-year median for Operating Expenses is $121941.0 (2024), against an average of $148934.5.
• Across the five-year window, Operating Expenses plunged 88.11% in 2023 and soared 423.14% in 2024, its largest moves.
• Bioadaptives' Operating Expenses stood at $28332.0 in 2022, then soared by 127.6% to $64483.0 in 2023, then jumped by 423.14% to $337339.0 in 2024, then declined by 24.2% to $255700.0 in 2025, then dropped by 20.87% to $202331.0 in 2026.
• The last three Operating Expenses figures came in at $202331.0 (Q1 2026), $255700.0 (Q4 2025), and $269540.0 (Q3 2025), per Business Quant data.